States Pause Lawsuits Against Insys During Bankruptcy Proceedings

Less than a month after filing for bankruptcy, embattled opioid drugmaker Insys Therapeutics saw a few bright spots this week, including a reprieve from some of the lawsuits against it, as well as a path forward for regulatory approval of an opioid overdose treatment.